Esperion Therapeutics, Inc.
GB ˙ LSE ˙ US29664W1053
3,13 $ ↓ -0,00 (-0,16%)
2026-06-05
DEL PRIS
SecurityGB:0IIM / Esperion Therapeutics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership4,291,711 shares
Latest Disclosed Value $ 11,759,289
UBS Group AG ownership in 0IIM / Esperion Therapeutics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 4,291,711 shares of Esperion Therapeutics, Inc. (GB:0IIM) valued at $11,665,300 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 313,353 shares of Esperion Therapeutics, Inc.. This represents a change in shares of 1,269.61% during the quarter. The current value of the position is $13,433,055 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (0IIM) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0IIM / Esperion Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 4,291,711 3,978,358 1,269.61 11,759 914.58 0.0003
2026-01-29 2025-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 313,353 -932,957 -74.86 1,159 -64.90 0.0002
2025-11-13 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,246,310 -290,902 -18.92 3,303 118.39 0.0005
2025-08-14 2025-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,537,212 867,294 129.46 1,513 56.85 0.0003
2025-05-13 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 669,918 -207,024 -23.61 965 -50.03 0.0002
2025-02-14 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 876,942 786,649 871.22 1,929 1,203.38 0.0004
2024-11-14 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 90,293 22,117 32.44 149 -1.99 0.0000
2024-08-14 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 68,176 46,776 218.58 151 164.91 0.0000
2024-05-13 2024-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 21,400 240 1.13 57 -9.52 0.0000
2024-02-09 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 21,160 -10,000 -32.09 63 110.00 0.0000
2023-11-09 2023-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 31,160 -24,042 -43.55 31 -60.53 0.0000
2023-08-11 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 55,202 -8,389 -13.19 77 -24.75 0.0000
2023-05-12 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 63,591 40,130 171.05 101 -30.82 0.0000
2023-02-08 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 23,461 9,377 66.58 146 53.68 0.0001
2022-11-10 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 14,084 -2,370 -14.40 95 -8.65 0.0000
2022-08-10 2022-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 16,454 2,610 18.85 104 62.50 0.0000
2022-05-16 2022-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 13,844 -50,898 -78.62 64 -80.19 0.0000
2022-02-14 2021-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 64,742 30,226 87.57 323 -22.36 0.0001
2021-11-15 2021-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 34,516 -18,624 -35.05 416 -62.99 0.0001
2021-08-13 2021-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 53,140 -13,435 -20.18 1,124 -39.80 0.0004
2021-05-12 2021-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 66,575 52,296 366.24 1,867 403.23 0.0006
2021-02-11 2020-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 14,279 -9,279 -39.39 371 -57.60 0.0001
2020-11-12 2020-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 23,558 -32,690 -58.12 875 -69.68 0.0003
2020-07-31 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 56,248 -30,175 -34.92 2,886 5.91 0.0012
2020-05-01 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 86,423 21,458 33.03 2,725 -29.66 0.0013
2020-02-14 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 64,965 53,670 475.17 3,874 835.75 0.0013
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 11,295 -3,452 -23.41 414 -39.65 0.0002
2019-08-14 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 14,747 -10,074 -40.59 686 -31.19 0.0003
2019-05-14 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 24,821 -160,621 -86.62 997 -88.31 0.0004
2019-02-14 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 185,442 114,538 161.54 8,531 171.17 0.0039
2018-11-14 2018-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 70,904 30,941 77.42 3,146 100.89 0.0012
2018-08-14 2018-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 39,963 -70,919 -63.96 1,566 -80.47 0.0007
2018-05-15 2018-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 110,882 26,975 32.15 8,020 45.18 0.0035
2018-02-14 2017-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 83,907 -20,284 -19.47 5,524 5.76 0.0023
2017-11-14 2017-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 104,191 -47,870 -31.48 5,223 -25.79 0.0024
2017-11-14 2017-06-30 13F/A-1 ESPERION THERAPEUTICS INC NE COM 29664W105 152,061 50,930 50.36 7,038 97.09 0.0036
2017-08-14 2017-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 152,061 50,930 7,038
2017-11-14 2017-03-31 13F/A-1 ESPERION THERAPEUTICS INC NE COM 29664W105 101,131 52,712 108.87 3,571 489.27 0.0019
2017-05-12 2017-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 101,131 52,712 3,571
2017-02-14 2016-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 48,419 -954 -1.93 606 -11.40 0.0003
2016-11-14 2016-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 49,373 35,292 250.64 684 388.57 0.0004
2016-08-12 2016-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 14,081 2,834 25.20 140 -26.32 0.0001
2016-05-12 2016-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 11,247 -131,765 -92.14 190 -94.03 0.0001
2016-02-16 2015-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 143,012 80,215 127.74 3,183 114.78 0.0021
2015-11-13 2015-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 62,797 49,752 381.39 1,482 39.02 0.0010
2015-08-14 2015-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 13,045 12,422 1,993.90 1,066 1,737.93 0.0007
2015-05-14 2015-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 623 -4,034 -86.62 58 -69.31 0.0000
2015-02-17 2014-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 4,657 4,657 189 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-05-13 2024-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-09 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 215,000 643 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-07-31 2020-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-01 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 50,000 1,577 n/a n/a n/a
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 10,000 465 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.